Intellipharmaceutics International Inc. filed its Annual on Jun 05, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% | -11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.93M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt